Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

TFG_Sanchez_Sara.pdf (3.37 MB)

Document type

Bachelor thesis

Publication date

2022-06

Publication license

cc-by-nc-nd (c) Sara Sánchez, 2022
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/189087

The microbiota-gut-brain axis: from dysbiosis to neurodegenerative disease

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

Abstract

The relation between the gut and the brain has been discussed for years, but the concept of gut microbiota (GM) has not been linked for so long. Having suggested its involvement in neurodegenerative disorders, this literature review aims to summarise the current knowledge on the possible bidirectional pathways that could explain it, while discussing the composition and alterations of the GM and the main pathological features that characterise neurodegeneration. It also presents the existing scientific evidence on the use of GM as a therapeutic target, accompanied by a systematic review-meta-analysis that evaluates the indication of one of the possible interventions: the faecal microbiota transplantation (FMT). GM is made up of the trillions of microorganisms in the gut, mostly bacteria, which interact dynamically with the host, contributing to both health and disease. These, through neural, endocrine and immune pathways, based on mechanisms that require further research, can modify the gut-brain axis promoting neurodegenerative processes such as neuroinflammation, protein misfolding and loss of integrity of the intestinal and blood-brain barriers, thus facilitating the passage of components derived from a deregulated GM that has been characterised in Alzheimer's and Parkinson's patients. Although more studies are needed, the promising results obtained in animal and more limited human trials, using GM modulating interventions such as oral bacteriotherapy or FMT, give hope for the cure and early detection of these increasingly prevalent diseases.

Description

Treballs Finals de Grau de Farmàcia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 2022. Tutor/a: Raquel Martín Venegas

Subject

Microbiota intestinal, Malalties neurodegeneratives, Treballs de fi de grau

Subject (English)

Gastrointestinal microbiome, Neurodegenerative Diseases, Bachelor's theses

Citation

Collections

Treballs Finals de Grau (TFG) - Farmàcia

Citation

SÁNCHEZ ARAGÓN, Sara. The microbiota-gut-brain axis: from dysbiosis to neurodegenerative disease. [consulted: 16 of August of 2026]. Available at: https://hdl.handle.net/2445/189087

Export metadata

JSON - METS

Share record